FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4225390826> ?p ?o ?g. }

• W4225390826 endingPage "531" @default.
• W4225390826 startingPage "523" @default.
• W4225390826 abstract "To provide in-depth understanding of real-world tumor necrosis factor inhibitor (TNFi) treatment patterns in patients with ankylosing spondylitis (AS) and treatment satisfaction, productivity loss, and associated factors.This was a multicenter observational hybrid retrospective chart review and cross-sectional survey study. Disease activity and physical functioning were measured using the Bath AS Disease Activity Index and Bath AS Functional Index, respectively. Treatment satisfaction was determined with the Treatment Satisfaction Questionnaire for Medication (TSQM). Productivity loss was evaluated using the Korean version of the World Health Organization-Health and Work Performance Questionnaire.A total of 497 patients were enrolled (mean age 40.3 years, 85.3% male, mean AS duration 10 years). The mean duration of TNFi treatment was 6.2 years. Among the four TNFi considered, adalimumab (39.6%) and etanercept (23.5%) were most commonly used at study enrollment. The TSQM convenience domain score was lower than scores in the effectiveness, adverse effects, and global satisfaction domains. Subcutaneous syringe-type injection and intravenous injection were associated with lower patient convenience satisfaction than subcutaneous pen-type injection. Increased costs of lost productivity time were associated with female sex, unemployed status, and higher disease activity.The most frequently prescribed TNFi was adalimumab, followed by etanercept. Etanercept was used for the longest duration. More convenient treatment options may enhance overall treatment satisfaction. Considerable loss in productivity due to AS was observed in this study. To reflect patients' perspectives, further attention should be paid to factors associated with treatment satisfaction and productivity loss when selecting treatment options." @default.
• W4225390826 created "2022-05-05" @default.
• W4225390826 creator A5000627464 @default.
• W4225390826 creator A5001474613 @default.
• W4225390826 creator A5001967366 @default.
• W4225390826 creator A5016731537 @default.
• W4225390826 creator A5054665860 @default.
• W4225390826 creator A5071928897 @default.
• W4225390826 creator A5074732724 @default.
• W4225390826 creator A5077563153 @default.
• W4225390826 creator A5080971885 @default.
• W4225390826 creator A5083309500 @default.
• W4225390826 date "2022-02-20" @default.
• W4225390826 modified "2023-10-16" @default.
• W4225390826 title "Treatment pattern, satisfaction, and productivity loss of patients with ankylosing spondylitis treated with tumor necrosis factor inhibitors in Korea: A multicenter cross‐sectional observational study" @default.
• W4225390826 cites W1266971073 @default.
• W4225390826 cites W1539633218 @default.
• W4225390826 cites W1545506009 @default.
• W4225390826 cites W1966756689 @default.
• W4225390826 cites W2011265813 @default.
• W4225390826 cites W2037296723 @default.
• W4225390826 cites W2064688760 @default.
• W4225390826 cites W2089211897 @default.
• W4225390826 cites W2091494006 @default.
• W4225390826 cites W2132482677 @default.
• W4225390826 cites W2134576557 @default.
• W4225390826 cites W2141467233 @default.
• W4225390826 cites W2144014410 @default.
• W4225390826 cites W2144181824 @default.
• W4225390826 cites W2150194035 @default.
• W4225390826 cites W2152734154 @default.
• W4225390826 cites W2163021619 @default.
• W4225390826 cites W2166444828 @default.
• W4225390826 cites W2226260683 @default.
• W4225390826 cites W2335619979 @default.
• W4225390826 cites W2474510828 @default.
• W4225390826 cites W2572897530 @default.
• W4225390826 cites W2593186219 @default.
• W4225390826 cites W2616568808 @default.
• W4225390826 cites W2753413334 @default.
• W4225390826 cites W2770625585 @default.
• W4225390826 cites W2794700162 @default.
• W4225390826 cites W2806852271 @default.
• W4225390826 cites W2890441806 @default.
• W4225390826 cites W2900712517 @default.
• W4225390826 cites W3004219983 @default.
• W4225390826 cites W4210974969 @default.
• W4225390826 cites W4225390826 @default.
• W4225390826 doi "https://doi.org/10.1111/1756-185x.14304" @default.
• W4225390826 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35187866" @default.
• W4225390826 hasPublicationYear "2022" @default.
• W4225390826 type Work @default.
• W4225390826 citedByCount "8" @default.
• W4225390826 countsByYear W42253908262022 @default.
• W4225390826 countsByYear W42253908262023 @default.
• W4225390826 crossrefType "journal-article" @default.
• W4225390826 hasAuthorship W4225390826A5000627464 @default.
• W4225390826 hasAuthorship W4225390826A5001474613 @default.
• W4225390826 hasAuthorship W4225390826A5001967366 @default.
• W4225390826 hasAuthorship W4225390826A5016731537 @default.
• W4225390826 hasAuthorship W4225390826A5054665860 @default.
• W4225390826 hasAuthorship W4225390826A5071928897 @default.
• W4225390826 hasAuthorship W4225390826A5074732724 @default.
• W4225390826 hasAuthorship W4225390826A5077563153 @default.
• W4225390826 hasAuthorship W4225390826A5080971885 @default.
• W4225390826 hasAuthorship W4225390826A5083309500 @default.
• W4225390826 hasBestOaLocation W42253908262 @default.
• W4225390826 hasConcept C126322002 @default.
• W4225390826 hasConcept C141071460 @default.
• W4225390826 hasConcept C142052008 @default.
• W4225390826 hasConcept C142724271 @default.
• W4225390826 hasConcept C1862650 @default.
• W4225390826 hasConcept C23131810 @default.
• W4225390826 hasConcept C2775944032 @default.
• W4225390826 hasConcept C2776260265 @default.
• W4225390826 hasConcept C2777226972 @default.
• W4225390826 hasConcept C2777402515 @default.
• W4225390826 hasConcept C2777453003 @default.
• W4225390826 hasConcept C2777575956 @default.
• W4225390826 hasConcept C2779134260 @default.
• W4225390826 hasConcept C2780132546 @default.
• W4225390826 hasConcept C71924100 @default.
• W4225390826 hasConceptScore W4225390826C126322002 @default.
• W4225390826 hasConceptScore W4225390826C141071460 @default.
• W4225390826 hasConceptScore W4225390826C142052008 @default.
• W4225390826 hasConceptScore W4225390826C142724271 @default.
• W4225390826 hasConceptScore W4225390826C1862650 @default.
• W4225390826 hasConceptScore W4225390826C23131810 @default.
• W4225390826 hasConceptScore W4225390826C2775944032 @default.
• W4225390826 hasConceptScore W4225390826C2776260265 @default.
• W4225390826 hasConceptScore W4225390826C2777226972 @default.
• W4225390826 hasConceptScore W4225390826C2777402515 @default.
• W4225390826 hasConceptScore W4225390826C2777453003 @default.
• W4225390826 hasConceptScore W4225390826C2777575956 @default.
• W4225390826 hasConceptScore W4225390826C2779134260 @default.
• W4225390826 hasConceptScore W4225390826C2780132546 @default.
• W4225390826 hasConceptScore W4225390826C71924100 @default.
• W4225390826 hasIssue "5" @default.

• next